TrialRMD open2025

Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial.

Yves Henrotin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.